Use access key #2 to skip to page content.
$38.28 -3.04 (-7.36%)
10/15/2008 4:00 PM

Gilead Sciences, Inc. (GILD)

CAPS Rating:
****

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

View All Commentary (GILD)

Recs

3

Avatar Hogwired1 (57.31) Submitted: 8/18/06 6:01 PM : Outperform Start Price: $31.78 GILD Score: 51.19

GILD is a solidly run biotech with an outstanding balance sheet and industry leading aids franchise. This company has substantially outperformed the market and should continue to outperform.

Report this Post Replies: 0 | Reply

Featured Broker Partners

Sponsored Links